Global Medical REIT Inc. (GMRE)
NYSE: GMRE · Real-Time Price · USD
7.69
+0.17 (2.19%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Global Medical REIT Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Global Medical REIT stock have an average target of 10.88, with a low estimate of 10 and a high estimate of 11.75. The average target predicts an increase of 41.57% from the current stock price of 7.69.
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 18, 2024.
Analyst Ratings
The average analyst rating for Global Medical REIT stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citizens Capital Markets | Citizens Capital Markets | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 12, 2025 |
| Berenberg | Berenberg | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +52.90% | Oct 18, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $11 → $10 | Strong Buy | Maintains | $11 → $10 | +30.12% | May 13, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $12 → $11 | Strong Buy | Maintains | $12 → $11 | +43.14% | May 8, 2023 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $14 → $12 | Strong Buy | Maintains | $14 → $12 | +56.15% | Mar 6, 2023 |
Financial Forecast
Revenue This Year
149.71M
from 138.76M
Increased by 7.89%
Revenue Next Year
154.40M
from 149.71M
Increased by 3.13%
EPS This Year
0.09
from 0.01
Increased by 646.40%
EPS Next Year
0.04
from 0.09
Decreased by -55.56%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 161.0M | 167.9M | 168.1M | |
| Avg | 149.7M | 154.4M | 158.2M | |
| Low | 140.2M | 142.1M | 147.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 16.0% | 12.1% | 8.9% | |
| Avg | 7.9% | 3.1% | 2.4% | |
| Low | 1.0% | -5.1% | -4.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.17 | 0.12 | 0.09 |
| Avg | 0.09 | 0.04 | 0.09 |
| Low | 0.05 | -0.05 | 0.09 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1,266.0% | 25.8% | 131.6% |
| Avg | 646.4% | -55.6% | 125.0% |
| Low | 298.4% | - | 116.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.